One important cytokine that has been delivered by NSCs in gliomas is the Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL), which is capable of inducing apoptosis in tumor cells with little effect on normal cells. This evidence concerns the gene TNFSF10 and central nervous system cancer.